×
Site Menu
Everything
International Coverage
Legalization
Local Collectives
Investing
Mental Health
Recreation
Mushroom Culture
New Tech
Publications
Mushroom Science
Physical Benefits
Maine lawmakers pass bill to study psychedelic regulation
Clearmind signs agreement with Hebrew University for psychedelic compound rights
Numinus reports declining revenue as the company restructures
Filament’s pivots pay off, nets $2.1M revenue in 2023
MindMed taps out of Cboe
Algernon sells Ifenprodil, zooms in on DMT for stroke care
Compass Pathways co-founders exit to pursue ‘broader goals’
Atai cash purse down nearly half despite lower spending
Atai nasal spray hits mark in depression study
Alto Neuroscience is enjoying a solid cash cushion
Latest
Maine lawmakers pass bill to study psychedelic regulation
22 hours ago
4
Clearmind signs agreement with Hebrew University for psychedelic compo...
23 hours ago
4
Numinus reports declining revenue as the company restructures
4 days ago
10
Filament’s pivots pay off, nets $2.1M revenue in 2023
2 weeks ago
18
MindMed taps out of Cboe
2 weeks ago
12
Algernon sells Ifenprodil, zooms in on DMT for stroke care
2 weeks ago
26
Compass Pathways co-founders exit to pursue ‘broader goals’
2 weeks ago
28
Atai cash purse down nearly half despite lower spending
3 weeks ago
28
Atai nasal spray hits mark in depression study
3 weeks ago
21
Alto Neuroscience is enjoying a solid cash cushion
3 weeks ago
21
Enveric Biosciences pins hopes on licensing deals
3 weeks ago
24
Psychedelic therapy program to launch in Utah
3 weeks ago
23
Relmada Therapeutics trims losses, slashes research costs
4 weeks ago
17
Seelos Therapeutics swings and misses on ALS drug study
4 weeks ago
18
Swedish study looks at psychedelic treatments for teens with psychotic...
1 month ago
24
Cybin to raise $150 million through private placement
1 month ago
38
BlueSky Wellness scraps merger with Lucy Scientific
1 month ago
37
JAMA article urges more surveillance over ketamine treatments
1 month ago
38
Mynd Life Sciences cuts losses, but faces going concern doubts
1 month ago
63
Atai kicks off DMT Phase 1 study
1 month ago
34
Compass widens Q4 loss as patient hurdles slow trials
1 month ago
71
Braxia Scientific cash dwindles even as revenues rise
1 month ago
61
GH Research pushes forward with DMT trials, drug approvals
1 month ago
56
Red Light Holland loses C$1.2 million in latest quarter
1 month ago
41
Psyence reports no revenue in Q4, but returns a profit
1 month ago
61
Psilocybin treatment beats placebo in Incannex anxiety study
1 month ago
49
Clearmind trials new alcohol disorder fix
1 month ago
63
Enveric sells cannabis patents to focus on psilocin candidates
1 month ago
57
Magic Mushroom Edibles: Everything to Know, from Chocolates to Drops
1 month ago
74
Psilocybin study for bipolar depression encourages more research
1 month ago
45
Prepping the psychedelic industry for MDMA approval
1 month ago
62
Pending Patents: Can Any Company Own Psilocybin?
1 month ago
45
Viridian Capital finds psychedelic stocks typically trade at 3x book
1 month ago
41
Filament Health exports psilocybin to Israel
2 months ago
55
Cybin reports strong cash reserves amid rising R&D costs in Q3
2 months ago
51
Bright Minds trims losses, but deficit grows
2 months ago
62
Doctor sues DEA to treat terminally ill patients with psilocybin
2 months ago
76
Police Officers Are Doing Ayahuasca Now
2 months ago
92
Study finds psychedelic users crowdsource to find ‘trip killers’
2 months ago
71
Study: Police seizures of psilocybin up 369% since 2017
2 months ago
74
Clearmind’s psychedelic portfolio expands with new Chinese patent
2 months ago
80
2024 kicks off with more states drafting psychedelic drug laws
2 months ago
101
Investors rally behind Numinus Wellness in a $6M bought deal
2 months ago
85
Oversubscribed and upsized Alto Neurosciences IPO begins trading today...
2 months ago
78
Numinus Wellness sells its stake in Alto Neurosciences
2 months ago
60
Huxley Health finalizes Sintalica deal, names Bruce Linton as new Chai...
2 months ago
102
Horizons ETFs to close cannabis, psychedelic funds in March
2 months ago
76
What’s in store for psychedelics in 2024
2 months ago
63
Tara Mind attracts $8M to bring ketamine therapy to workplace benefits...
2 months ago
64
EU awards €6.5 million for psychedelic drug trial
2 months ago
58
Prev.
1
2
3
4
Next
Last
Trending
1.
Alchemy
2.
Israel
3.
Clara Bow
4.
Joe Alwyn
5.
Travis Kelce and Taylor Swift
6.
Kerry Kennedy
7.
Hailey Van Lith
8.
Aston Villa
9.
Atalanta vs Liverpool
10.
Florida communism bill
Popular
Therapists Are Unprepared to Talk to People About Taking Psychedelics
What We Know (and Don’t) About Magic Mushroom Paralysis
How To Talk With Your Kids About Psychedelics
Uniform Model Law on Plants and Fungi Medicines: A Better Path to Reregulation
Psychedellux: The Psychedelic Industry News For The Week